Extrapulmonary neuroendocrine carcinoma (ep-nec)

Clinical trials for Extrapulmonary neuroendocrine carcinoma (ep-nec) explained in plain language.

Never miss a new study

Get alerted when new Extrapulmonary neuroendocrine carcinoma (ep-nec) trials appear

Sign up with your email to follow new studies for Extrapulmonary neuroendocrine carcinoma (ep-nec), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 1

Can a Triple-Drug combo outsmart a rare and aggressive cancer?

Disease control Not yet recruiting

This clinical trial is testing whether adding two newer drugs—QL1706 and lenvatinib—to standard chemotherapy can help people with a rare and aggressive cancer called extrapulmonary neuroendocrine carcinoma (EP-NEC). The study will compare the combination against chemotherapy alon…

Matched conditions: EXTRAPULMONARY NEUROENDOCRINE CARCINOMA (EP-NEC)

Phase 2 • Sponsor: West China Hospital • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC

Extrapulmonary neuroendocrine carcinoma (ep-nec)

Get alerted when new Extrapulmonary neuroendocrine carcinoma (ep-nec) trials appear

Can a Triple-Drug combo outsmart a rare and aggressive cancer?